Susan Wedley - Concepedia

Author

Susan Wedley

Eli Lilly (United Kingdom)

Also Known As

S. WEDLEY, Susan Wedley

Publications

282

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United Kingdom)Eli Lilly (United States)

About

Susan Wedley is an author at Eli Lilly (United Kingdom) specializing in medicine, pharmacology, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	258
2	Biochemistry	3	3	86
3	Health Sciences	2	2	66
4	Social Sciences	2	2	92
5	Natural Sciences	1	1	21

Susan Wedley

Publications

258

Citations

H-Index

Page 1

	Year	Citations
Actions of arginine polyamine on voltage and ligand‐activated whole cell currents recorded from cultured neurones Roderick H. Scott, Marva I. Sweeney, Evgeny Kobrinsky, British Journal of Pharmacology Synaptic TransmissionNeurotransmitterNeurotransmissionCellular NeurobiologySynaptic Signaling	1992	52
LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine2A receptor antagonist: a comparison with the antidepressant, nefazodone Ian A. Pullar, Stephen Carney, Ellen M. Colvin, European Journal of Pharmacology Psychiatry5-Hydroxytryptamine TransporterMedicinePsychotropic MedicationPhysiology	2000	50
ω-Agatoxin IVA identifies a single calcium channel subtype which contributes to the potassium-induced release of acetylcholine, 5-hydroxytryptamine, dopamine, γ-aminobutyric acid and glutamate from rat brain slices Janette Harvey, Susan Wedley, Jeremy Findlay, Neuropharmacology Synaptic TransmissionNeurotransmitterNeurotransmissionSynaptic SignalingSocial Sciences	1996	40
The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig Ian A. Pullar, John R. Boot, Richard J. Broadmore, European Journal of Pharmacology Molecular PhysiologyNeurophysiologyMedicineFunctional SelectivityPhysiology	2004	37
The effects of standard neuroleptic compounds on the binding of 3H-spiroperidol in the striatum and mesolimbic system of the rat in vitro Joy L. Howard, Bruce T. Large, Susan Wedley, Life Sciences NeurophysiologyMedicineStandard Neuroleptic CompoundsPhysiologyNeurotransmitter	1978	29
Effects of conformationally restricted 4-piperazinyl-10H-thienobenzodiazepine neuroleptics on central dopaminergic and cholinergic systems Jiban K. Chakrabarti, Terrence M. Hotten, Sarah E. Morgan, Journal of Medicinal Chemistry Central DopaminergicDistal Piperazine NitrogenPharmacotherapyMedicinal ChemistryCholinergic Systems	1982	21
SAR development of a selective 5-HT1D antagonist/serotonin reuptake inhibitor lead using rapid parallel synthesis Graham H. Timms, John R. Boot, Richard J. Broadmore, Bioorganic & Medicinal Chemistry Letters Sar DevelopmentInhibitor LeadFunctional SelectivityMedicineDrug Discovery	2004	16
In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT1B/1D/2 receptor antagonist properties Ian A. Pullar, John R. Boot, Stephen Carney, European Journal of Pharmacology Molecular PharmacologyBiochemistry5-Hydroxytryptamine TransporterMedicineFunctional Selectivity	2001	13

Page 1